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ABSTRACT
Objective: To identify practice strategies associated
with higher ﬂu vaccination rates in primary care.
Design: Logistic regression analysis of data from
a cross-sectional online questionnaire.
Setting: 795 general practices across England.
Participants: 569 practice managers, 335 nursing
staff and 107 general practitioners.
Primary outcome measures: Flu vaccination rates
achieved by each practice in different groups of at-risk
patients.
Results: 7 independent factors associated with
higher vaccine uptake were identiﬁed. Having a lead
staff member for planning the ﬂu campaign and
producing a written report of practice performance
predicted an 8% higher vaccination rate for at-risk
patients aged <65 years (OR 1.37, 95% CI 1.10 to
1.71). These strategies, plus sending a personal
invitation to all eligible patients and only stopping
vaccination when Quality and Outcomes Framework
targets are reached, predicted a 7% higher vaccination
rate (OR 1.45, 95% CI 1.10 to 1.92) in patients aged
$65 years. Using a lead member of staff for
identifying eligible patients, with either a modiﬁed
manufacturer’s or in-house search programme for
interrogating the practice IT system, independently
predicted a 4% higher vaccination rate in patients aged
$65 years (OR 1.22, 95% CI 1.06 to 1.41/OR 1.20,
95% CI 1.03 to 1.40). The provision of ﬂu vaccine by
midwives was associated with a 4% higher vaccination
rate in pregnant women (OR 1.19, 95% CI 1.02
to 1.40).
Conclusions: Clear leadership, effective
communication about performance and methods used
to identify and contact eligible patients were
independently associated with signiﬁcantly higher
rates of ﬂu vaccination. Financial targets appear to
incentivise practices to work harder to maximise
seasonal inﬂuenza vaccine uptake. The strategies
identiﬁed here could help primary care providers to
substantially increase their seasonal ﬂu vaccination
rates towards or even above the Chief Medical Ofﬁcer’s
targets.
INTRODUCTION
Inﬂuenza
Inﬂuenza (ﬂu) is a common potentially
severe but preventable infection that places
a high burden on patients and healthcare
providers.
1 2 A safe and effective inactivated
(killed) vaccine is produced ahead of each
ﬂu season, based on strain recommendations
provided by WHO and is offered to at-risk
groups in the UK free of charge.
3e6 These
groups have been chosen based on evidence
showing increased risk of severe ﬂu infection
To cite: Dexter LJ, Teare MD,
Dexter M, et al. Strategies to
increase inﬂuenza
vaccination rates: outcomes
of a nationwide
cross-sectional survey of UK
general practice. BMJ Open
2012;2:e000851.
doi:10.1136/
bmjopen-2011-000851
< Prepublication history and
additional tables for this
paper are available online. To
view these ﬁles please visit
the journal online (http://dx.
doi.org/10.1136/
bmjopen-2011-000851).
Received 6 January 2012
Accepted 3 April 2012
This ﬁnal article is available
for use under the terms of
the Creative Commons
Attribution Non-Commercial
2.0 Licence; see
http://bmjopen.bmj.com
For numbered afﬁliations see
end of article.
Correspondence to
Laura J Dexter;
l.dexter@shefﬁeld.ac.uk
ARTICLE SUMMARY
Article focus
- Uptake of seasonal inﬂuenza vaccination in the
UK’s at-risk population is below the national and
international target of 75%.
- Evidence-based guidance, to advise practices
how to optimise all aspects of their ﬂu vaccina-
tion campaigns and maximise their likelihood of
protecting at-risk patients against ﬂu and its
serious sequelae, is greatly needed.
- This study sought to identify which strategies
and procedures were associated with higher
rates of ﬂu vaccine uptake.
Key messages
- This study has identiﬁed seven key strategies
that were signiﬁcantly associated with the
success of practices’ seasonal ﬂu vaccination
campaigns.
- If widely implemented by general practices,
average vaccination rates would be predicted to
rise by 7%e8% (thereby exceeding WHO target
in patients aged >65 years).
Strengths and limitations of this study
- The study sample was large and representative,
despite a participation rate of only 27.5%.
- Outcome measures (vaccination rates) were
objective and corrected for practice size.
- Strategies used to provide and encourage
vaccination were self-reported.
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Open Access Researchor sequelae: epidemiological data from 2010 to 2011
indicated that patients in a risk group due to chronic
disease had a 10-fold greater risk of mortality due to
inﬂuenza compared with those who were not in an at-
risk group.
1 During the 2010e2011 ﬂu season, 602
deaths in the UK were due directly to inﬂuenza.
1 Of
those who died, approximately two-thirds were in a clin-
ical risk group that is targeted for vaccination, while only
25% had received vaccination for that season.
WHO guidance indicates that developed countries
should achieve 75% inﬂuenza vaccine coverage in older
people, while the European Union Council (EC) advises
that members should aim to vaccinate 75% of all those at
high risk from inﬂuenza infection.
7 8 England’s Chief
Medical Ofﬁcer (CMO) has instructed that, in
2011e2012, each practice should aim to reach or exceed
75% uptake for people aged 65 years or over and 60%
uptake for at-risk people under age 65 (increasing to 75%
by 2013/2014).
6 Published data suggest that approxi-
mately 27% of England’s population was eligible for free
ﬂu vaccination in 2010.
91 0Providing seasonal inﬂuenza
vaccination is a large and complex task, which is
performed well in the UK, in comparison to many other
European countries.
11 Over 10 million patients were
vaccinated in England in the 2010e2011 season: each
general practice vaccinating an average of approximately
1000 patients, mostly within a period of 4e6w e e k s .T h e
proportion of people aged over 65 years in England who
received the 2010/2011 inﬂuenza vaccine was, at 72.8%,
just below the target of 75%.
9 However, both past and
current rates of vaccination in the under 65 at-risk groups
fall far short of the EC or CMO targets: during 2010/
2011, the rate achieved was 50.4%; in pregnant women
who were not otherwise at risk it was only 36.6%, despite
increasing evidence showing the beneﬁcial effects of
protection against ﬂu for both mothers and babies.
91 2 e14
A few previous studies have investigated the utility
of speciﬁc interventions (such as telephone calls or
letters) to generate an increase in uptake, but an optimal
overall strategy for primary care providers remains
undeﬁned.
15 16 In this study, we aimed to investigate the
entire process of ﬂu vaccine provision in a wide range of
UK general practices in order to determine the correlates
of higher vaccine uptake and to inform comprehensive
evidence-based recommendations for best practice.
METHODS
Survey development
Individual or small-group interviews with general practi-
tioners (GPs), nurses and practice managers from six
practices already achieving high rates of ﬂu vaccination
in urban (city), semi-rural (market town) and rural
(village) areas were carried out, during which staff were
asked to identify the factors considered by practices in
designing and carrying out their ﬂu vaccination
campaigns. The information gained was used to
construct three online questionnaires (one each for the
participating groups of GPs, practice managers and
practice nurses), using the Survey Monkey web-based
software.
17 The format of the questions and the layout of
the questionnaires were designed to optimise the statis-
tical utility of the data to be collected. The question-
naires were piloted in the same six practices to further
ascertain relevance and usability before ﬁnal distribution.
Questionnaire distribution and survey participants
We aimed to distribute the questionnaires to all regis-
tered GPs, practice nursing staff and practice managers
within four Strategic Health Authorities (SHAs) (East
Midlands, London, West Midlands and Yorkshire and
Humber), which together provide care for approximately
40% of the UK population. Details about the survey were
sent via the Public Health teams in the participating
SHAs, who were requested to cascade the information to
members of individual primary care teams (GPs, nurses
and practice managers) in their area via normal elec-
tronic information circulation mechanisms. The same
method was used for all other communications with
participants during the study. A preliminary email,
containing a letter informing primary care teams about
the forthcoming study, was distributed 2 weeks before the
ﬁrst survey invitation. Two emails, inviting participation
in the survey and containing web links to the online
questionnaires, were then distributed in two consecutive
weeks during August 2011.
Vaccine uptake data and other comparators
The Immform web service, which is a UK Department of
Health website for collecting vaccination data from
general practices, was used to obtain practice-level ﬂu
vaccination uptake data for the period 1 September 2010
to 28 February 2011.
18 Actual numbers vaccinated and
actual numbers eligible were recorded for 65+-year-olds
and at-risk <65-year-olds (including pregnant women).
These are standard groups used for targeting and
measuring inﬂuenza vaccine uptake by WHO. Total
practice population size was also recorded. Other prac-
tice-level data, including summary Quality and
Outcomes Framework (QOF) scores (most recent data
available for April 2009 to March 2010) and a variety of
demographic measures, were obtained in order to
identify and/or adjust for other factors which may
differentially affect vaccine uptake rates (such as overall
practice quality performance, practice size, population
ethnicity or population deprivation).
19 20 QOF is
a programme of annual ﬁnancial rewards for GP
surgeries, which forms part of the GP contract in
England and Wales.
21 The above information was linked
to the questionnaire responses by NHS practice code (a
unique six-ﬁgure identiﬁer); codes were then removed
from the data set prior to analysis.
Statistical analyses
In addition to a full descriptive analysis of the variables
recorded in the questionnaires, logistic regression anal-
yses were performed using STATA to compare the
proportions of patients vaccinated across different
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Increasing inﬂuenza immunisationcategorical responses in the survey questionnaire. The
logistic regression was based upon absolute numbers of
patients vaccinated out of the total at-risk to account for
differences in at-risk practice population size. Potentially
confounding variables, such as total practice size, Index
of Multiple Deprivation and proportion white ethnicity,
were analysed for correlation with vaccination uptake
and adjusted for in the univariable analyses where
appropriate. As there was not always complete agree-
ment in questionnaire responses received from different
participants in the same practice, robust standard errors
were computed using a cluster correction model,
thereby generating data corrected to the practice level.
Multivariable regression analysis was then performed on
any two or more results from the same subset(s) of
participants (ie, practice managers, nurses and/or GPs),
which showed signiﬁcance at the 95% level on univari-
able analysis.
RESULTS
Fifty primary care trusts distributed the survey invitation
to a total of 2896 practices. Responses were submitted by
569 practice managers, 335 nursing staff and 107 GPs,
representing 795 practices (27.5% of those invited to
contribute). These practices serve a total of approxi-
mately 5.8 million patients, among whom over 1.5
million are eligible for inﬂuenza vaccination. The
distributions of ﬂu vaccination rates in the surveyed
practices were well matched to national patterns
(ﬁgure 1). For the majority of eligible patients (ie, those
aged 65 years and above), our ﬁndings indicated that
the variation between practices’ ﬂu vaccination rates was
not inﬂuenced by differences in the ethnicity or afﬂu-
ence of their patient populations, whereas Quality and
Outcomes Framework summary scores showed highly
and signiﬁcant positive correlations with vaccine uptake
achieved in both age groups (supplementary table 1).
The univariable logistic regression results referred to
throughout this section are shown in supplementary
table 2.
Stafﬁng
Having a lead member of staff for arranging the practice
ﬂu vaccination campaign was associated with increased
ﬂu vaccine uptake rates in both 65+ and <65 age groups
(p¼0.001 and 0.004, respectively). Nominating a staff
member with responsibility for identifying eligible
patients was associated with increased uptake of vaccine
in older age groups (p¼0.038), but this trend, although
present, did not reach signiﬁcance in under 65s
(p¼0.218).
Ordering vaccine
A plot of the number of vaccine doses ordered for
2011e2012 versus vaccines used in 2010e2011 shows
a tight correlation (ﬁgure 2A). On average, practices
were found to have ordered vaccines based on the
number of doses given in the previous season, with an
average uplift of 8.8% (95% CI 4.3% to 13.3%; n¼568).
As vaccines are ordered as a total, these data could not
be differentiated into doses intended for vaccination of
patients aged over or under 65 years old. However, the
data showed that only 78.3% of responding practices
would have been able to vaccinate at least 75% of
their at-risk patients (in accordance with the CMO
recommendations) (ﬁgure 2B).
Contacting patients
Using personal invitations, either alone or in combina-
tion with general publicity, was signiﬁcantly associated
with higher rates of vaccination. The use of personal
invitations for all patients (not just those who did not
respond to an initial general publicity campaign) was
associated with the highest vaccination rates in the larger
65+ age group (p¼0.003), although a similar association
did not reach statistical signiﬁcance in the under 65s.
Using both letters and telephone calls was not associated
with signiﬁcantly different vaccination rates than using
either letters or phone calls alone (p¼0.721 for patients
aged 65+; p¼0.852 for patients aged <65).
Identifying eligible patients
Programmes for identifying eligible patients from the
practices’ IT system are usually issued by the software
providers. Modifying the ITsupplier’s standard search or
creating a separate in-house search was associated with
signiﬁcantly higher uptake rates for patients aged 65
+ years than using an unmodiﬁed IT supplier’s search
(p<0.001 and 0.027, respectively). A similar trend for
under 65s did not reach statistical signiﬁcance, perhaps
due to insufﬁcient power. As older patients are identiﬁed
simply on the basis of their age at a certain date, which
should not require a complicated search strategy, these
ﬁndings suggest that creating or modifying a system
search reﬂects that the staff in these practices are more
Figure 1 Box and whisker plots showing the range and
distribution of inﬂuenza vaccination uptake rates for patients
aged 65+ years (blue boxes and bars) and at-risk patients
aged under 65 years (red boxes and bars). The distribution of
uptake rates for non-participating practices (N¼2101) and
participating practices (N¼795) are not signiﬁcantly different.
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Increasing inﬂuenza immunisationmotivated and/or experienced to use their IT system to
try to achieve their ﬂu vaccination targets.
Offering clinics and appointments
More than 95% of practices held the main vaccination
sessions at their usual surgery premises and 75% held
the main sessions during normal surgery hours. Most
practices reported using a variety of appointment types
and timings to provide ﬂu vaccination. Surprisingly, in
our data, offering vaccinations at weekends, or before
8:00 or after 18:00, was not associated with a signiﬁcant
difference in the vaccination uptake rates achieved.
Increasing numbers of reminders or repeat invitations
were associated with signiﬁcantly increased vaccine
uptake in the under 65-year-olds (p¼0.038), though not
in those aged 65+ years. Signiﬁcantly, higher rates of
vaccination (for under 65s) occurred in practices that
identiﬁed appointments for ﬂu vaccination using
a speciﬁc Read (computer identiﬁcation) code
(p¼0.038).
Vaccinating pregnant women
The proportion of practices that reported that their
community midwives recommended ﬂu vaccination to
Figure 2 (A) Relationship
between reported total number of
vaccine doses ordered for the
2011e2012 season and actual
number of doses administered in
2010e2011 (n¼568) and (B) plot
showing the maximum average
achievable vaccination rates for
the 2011e2012 season, based on
the total number of vaccine doses
ordered and the total number of
eligible patients. Red line indicates
the Chief Medical Ofﬁcer’s target
of 75%.
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Increasing inﬂuenza immunisationpregnant women was disappointingly low (57.5%).
Furthermore, there was a clear discrepancy between this
ﬁgure and the proportion that reported that their
community midwives actually administered vaccine
(17.8%; see ﬁgure 3A). Our analysis demonstrated that
practices where community midwives were active in
administering ﬂu vaccinations to pregnant patients
achieved signiﬁcantly higher rates of uptake in this
particular at-risk group (p¼0.023).
Ending and reviewing the campaign
A total of 578 practices provided information on what
inﬂuenced their decision to stop offering ﬂu vaccina-
tion. Of major concern was the evidence that almost
50% of practices stopped offering ﬂu vaccines partly, or
solely, because they had exhausted their stock. Almost
one-third (28.9%) cited a ﬁnancial factor in making
their decision and the data showed that ending ﬂu
vaccination only once QOF targets had been reached
was associated with increased uptake rates for those aged
65+ years (p¼0.048); in those aged under 65 years, this
was only weakly signiﬁcant (p¼0.100), perhaps inﬂu-
enced by the smaller numbers of patients in this group.
These results suggest that practices that focused on
ﬁnancial targets were motivated and/or organised to
continue their efforts to vaccinate patients beyond the
point at which other practices may stop. In support of
this hypothesis, we found that patients whose vaccination
would contribute to a QOF-related payment received an
average of 42% (95% CI 33% to 51%) more reminders
more than those who did not have a QOF-registered
indication for vaccination (p<0.001).
Practices which produced a written report reviewing
their ﬂu vaccination rates achieved very signiﬁcantly
higher vaccination rates in both younger and older age
groups compared with those practices which did not
produce a written report (p¼0.006 for patients aged 65
+ years; p¼0.002 for patients aged <65 years). Similarly,
reviewing the practice’s ﬂu vaccination strategy in
a written format was also signiﬁcantly associated with
achieving higher rates of vaccination (p¼0.067 for
patients aged 65+ years; p¼0.028 for patients aged
<65 years). This ﬁnding suggests that practices that
produced written reports may have been able to organise
more rigorous campaigns and/or have had more well-
informed and motivated staff, resulting in more effective
performance.
Personal motivations and attitudes of staff
Figure 3B shows a summary of GPs’, nurses’ and practice
managers’ views of the ﬂu vaccination campaign. There
was a signiﬁcant association between encouraging
vaccination among colleagues and other staff and
achieving higher rates of vaccine uptake in patients aged
65 years or above (p¼0.004) but not in those aged under
65 years (p¼0.208). There was a trend for a similar
association between positive attitudes of staff towards
being vaccinated themselves and higher rates of patient
vaccination in a practice, but this did not reach statistical
signiﬁcance in either the older or younger age group
(p¼0.440 and 0.185, respectively).
Predicted impact of strategies to increase rates of inﬂuenza
vaccination
Seven factors were found to have signiﬁcant indepen-
dent positive associations with ﬂu vaccine uptake levels
following multivariable regression analysis (tables 1
and 2). For patients aged <65 years, having a lead
member of staff for planning the ﬂu campaign and
producing a written report of the practice’s performance
were associated with a combined OR of 1.37, which
predicts an 8% higher ﬂu vaccination rate for practices
that employ these strategies compared with those that do
not (54% vs 46%).
In patients aged 65 years or over, a further two factors
were also found to remain independently correlated
with increased rates of ﬂu vaccination. These were
sending a personal invitation to all eligible patients and
Figure 3 Showing (A) the
reported activity of community
midwifery teams in recommending
and providing seasonal inﬂuenza
vaccination to pregnant women
and (B) the attitudes of
participating healthcare workers to
vaccination of colleagues and
themselves.
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reached. The overall OR associated with the imple-
mentation of all four strategies in this age group was
1.45, which predicts a 7% higher vaccination rate in this
age group when these strategies are used (78% vs 71%).
The strategies of using a lead member of staff for
identifying eligible patients and either a modiﬁed
manufacturer’s search programme or an in-house search
programme for interrogating the practice ITsystem were
also independently correlated with increased rates of ﬂu
vaccination in patients aged 65 years or more. However,
the effect seen was weaker as these data are derived from
a subset of responses from practice managers only,
suggesting a rise to 78% from a baseline of 74%.
The active involvement of midwives in providing ﬂu
vaccination was signiﬁcantly associated with higher levels
of vaccine uptake in pregnant women but, as the only
signiﬁcant variable within this group, the ﬁnding could
not be included in a multivariable analysis. However,
applying the OR of 1.20 predicted by the univariable
analysis, our data indicate that the provision of vaccina-
tion by midwives rather than GPs is associated with an
increase in uptake rate to 45% in pregnant women
(from an observed average baseline vaccination rate of
41% in our cohort).
DISCUSSION
This study has identiﬁed seven factors which GPs might
use to improve and maximise uptake of seasonal ﬂu
vaccine in at-risk patients. Many of these strategies are
common sense and align with the empirical guidance
given by the English and Scottish CMOs,
22 23 but our
study provides the ﬁrst statistical evidence to support the
validity of such approaches. The study sample was large
and appeared to be representative of the overall cohort,
despite a participation rate of only 27.5%. Although we
found no evidence for selection bias of participating
practice staff, when the vaccination rates of participating
practices were compared with national data, it remains
possible that the responses of staff who completed the
questionnaire did not reliably represent the views of all
practice staff within those participating practices.
However, most of our questions sought factual data
rather than opinions and so this bias, if present, is likely
to be limited.
This study focused on identifying strategies and
approaches that GPs might use or inﬂuence to improve
vaccine uptake. However, numerous patient-related
factors also affect ﬂu vaccine uptake. Highly mobile or
ethnically diverse populations may prove very difﬁcult to
contact and target for ﬂu vaccination. It is also likely that
a minority of patients will always refuse or miss vaccina-
tion, no matter how much GPs strive to provide it. Public
perception of inﬂuenza as a signiﬁcant threat to health
and of vaccination as an effective preventive strategy is
associated with higher uptake.
24 People who receive
information about these factors from ofﬁcial health
sources (particularly GPs or nurses in the primary care
Table 1 Statistically signiﬁcant factors found on multivariate regression analysis of responses common to all three types of
staff (general practitioners, nursing staff and practice managers)
Description of signiﬁcant factor
Regression
co-efﬁcient 95% CI p Value
Number
of clusters
For patients aged $65 years
Producing a written report to review ﬂu vaccine uptake rates 0.065 0.023 to 0.107 0.010 659
Having a lead member of staff for planning the practice’s
ﬂu vaccination campaign
0.144 0.035 to 0.253 0.010 659
Sending a personal invitation to all eligible patients 0.081 0.035 to 0.127 0.001 659
Only stopping vaccination when Quality and Outcomes
Framework targets are reached
0.085 0.004 to 0.166 0.039 659
For at-risk patients aged <65 years
Producing a written report to review ﬂu vaccine uptake rates 0.113 0.042 to 0.184 0.002 783
Having a lead member of staff for planning the practice’s
ﬂu vaccination campaign
0.203 0.054 to 0.352 0.008 783
Table 2 Statistically signiﬁcant factors found on multivariate regression analysis of responses from practice managers only
Description of signiﬁcant factor
Regression
co-efﬁcient 95% CI p Value
Number
of clusters
For patients aged $65 years
Identifying eligible patients using a modiﬁed manufacturer’s
search programme
0.115 0.056 to 0.175 0.000 395
Identifying eligible patients using an in-house search programme 0.096 0.028 to 0.163 0.006 395
Having a lead member of staff for identifying eligible patients
in the practice
0.086 0.001 to 0.170 0.046 395
For at-risk patients aged <65 years, no signiﬁcant factors were identiﬁed by multiple regression.
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Increasing inﬂuenza immunisationsetting) and who think that others want them to be
vaccinated are more likely to get vaccinated.
11 24 25 In
line with this, ﬂu vaccination uptake is greater among
older people and others who make routine use of
hospital and community care services.
26 Unsurprisingly,
fear of side effects of vaccination is a strong negative
inﬂuence, while lack of general motivation and igno-
rance about the recommendations are other commonly
reported barriers to both seasonal and pandemic vacci-
nation.
27 28 However, when intensive recall stimuli and
information are provided to at-risk patients, as few as
3.5% will refuse vaccination, suggesting that patient
attitudes are malleable and should not present a barrier
to achieving the CMO’s aims.
29 Our results strongly
support the provision of personal invitations for all
patients (in alternative languages and/or formats, if
required), as advised by the CMO.
22 However, we found
little evidence of beneﬁt from offering very early (before
8:00), late (after 18:00) or weekend appointments. This
contradicts some current guidance
22 and is likely to be of
ﬁnancially relevance for practices. Our ﬁndings with
respect to the ﬂu vaccination of pregnant women are
also important. Although administering ﬂu vaccine is
not part of the current role of many midwives, it is logical
that the ability both to discuss and to provide vaccination
to pregnant women would increase uptake in this risk
group by removing the need for referral and attendance
at a separate clinic: our analyses now support this logic.
However, if midwives were to provide inﬂuenza vaccina-
tion outside of the practice setting, it would be essential
for reliable records of this to be transferred to the GP.
The need for good communication with patients, to
encourage the uptake of ﬂu vaccination, is axiomatic.
However, several statistically signiﬁcant outcomes of our
analyses have not previously been described and are
directly or indirectly associated with the quality or extent
of communication within practices. The production of
a written review of practice performance might be asso-
ciated with higher ﬂu vaccination rates for a number of
reasons. Production of such a report indicates that at
least one member of staff must be able to access and
manipulate the relevant data using their practice’s
computer systems and is motivated to do so. Subsequent
dissemination of the report allows staff to become aware
of their practice’s performance and identify areas for
improvement. Only 20% of practices in our study
produced a written report of vaccine uptake rates and
this strategy is not currently recommended in the CMO
guidance for England. Our results also indicate that each
practice should nominate lead members of staff for
organising the practice’s inﬂuenza vaccination campaign
(as advised by the English and Scottish CMOs
22 23) and
for identifying at-risk patients from the practice data-
base. This is supported by a recently published study
from the USA, which suggested that effective use of
electronic databases by a skilled data manager could
increase the rate of ﬂu vaccination by over 10%.
30 The
ability to perform a modiﬁed or in-house search of the
practice’s patient database is unlikely to improve the
simple process of identiﬁcation of those aged over
65 years. However, a member of staff who is thoroughly
familiar with the IT system may be more able to
contribute to improved rates of vaccination by, for
example, monitoring levels of appointment bookings
and vaccine uptake in real-time throughout the
campaign; generating automatic invitation and
reminder letters, text messages or emails; creating alert
ﬂags on the patient record to promote opportunist
vaccination. Our study’s ﬁndings also suggest that the
effectiveness of a practice’s ﬂu vaccination campaign is
increased when staff promote vaccination among them-
selves, an effect which may arise from increased moti-
vation for the campaign as a whole or through
communication of their positive attitude to at-risk
patients. This supports the ﬁndings of previous studies
and should thus contribute to an increased impetus to
encourage vaccination of staff.
31 32
The relationship between staff motivation and prac-
tice performance is neither simple nor exclusive. Indi-
viduals may have different motivations and their
interaction within a larger team may produce variable
outcomes. We do not argue that introducing written
reports and/or tailoring the practice search strategies
would necessarily increase motivation. However, in
practices where these actions are not already under-
taken, their introduction would ensure that staff
become more aware of the practice’s performance and
the underlying mechanisms that inﬂuence it. Having
found a highly signiﬁcant correlation of these strategies
with increased vaccine uptake, we propose that
increased awareness and knowledge may help to
increase staff motivation. However, our study was not
designed to measure motivation per se or its effects in
isolation and this would be an interesting (though
challenging) area for further study.
There is currently a signiﬁcant ﬁnancial risk for prac-
tices attempting to improve their vaccination rates. As
practices are only reimbursed on the basis of the number
of vaccines administered, they face a ﬁnancial penalty if
they buy more doses than are used and sale-or-return
schemes are usually limited to a few per cent of the
vaccine doses in the overall order. Perhaps as a result, we
have found that almost 50% of practices currently halt
their vaccination campaigns due to exhaustion of
vaccine stocks. A central procurement strategy for ﬂu
vaccines, which has recently undergone consultation by
the Department of Health, should remove this ﬁnancial
stricture and allow practices to aim for much higher
vaccination rates without risking ﬁnancial penalty.
33
However, this will also result in the loss of a signiﬁcant
proportion of practices’ funding for ﬂu vaccination (ie,
which is currently derived from any discrepancy between
tariff price and purchased price for the vaccine itself).
Considerable effort and resources are required to deliver
a successful ﬂu vaccination campaign, and our ﬁndings
indicate that practices’ efforts can be inﬂuenced by
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vaccination requires practice staff to be able to perform
complex interrogations of their patient database and to
be aware of rates of vaccine uptake while the ﬂu vacci-
nation campaign is progressing. Our data suggest that
pursuing the QOF targets may motivate practices to
maintain vaccine stocks and encourage extra patients to
receive vaccine. We would not advise that practices
should automatically stop vaccinating patients once their
QOF targets have been attained. However, our ﬁndings
suggest that a scale of ﬁnancially supported targets
applicable across all patient groups, or the inclusion of
ﬂu vaccination of all at-risk patients in the QOF scheme,
might be a powerful tool to increase ﬂu vaccine uptake.
Current vaccines achieve around 50%e80% protec-
tion against inﬂuenza and associated sequelae in at-risk
groups.
3 34e36 However, these efﬁcacy rates do not
translate into public health protection if the vaccine is
not delivered effectively to the communities that need it.
With ﬂu vaccination rates varying from 15% to 100%
(ﬁgure 1) between the worst and best practices in our
nationwide cohort, there is the potential for enormous
gains to be made. This study has identiﬁed seven simple
steps that can improve our performance and increase
the protection of at-risk patients.
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